Claybrook Capital’s Omnicell OMCL Stock Holding History

Claybrook Capital’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-276	Closed	-$17K	–	498
2018 Q4	$17K	Buy	+276	New	+$18.7K	﹤0.01%	389

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Claybrook Capital's OMCL Position: Q1 2019 in Review

Claybrook Capital sold out of Omnicell (OMCL) in Q1 2019, closing a stake of 276 shares — an estimated $17K sold.

Claybrook Capital first reported a position in OMCL in Q4 2018 and held it in 1 quarter. The position peaked at $17K in Q4 2018. 306 funds tracked by Wall St. Rank hold OMCL as of Q1 2019.

Claybrook Capital reported no remaining Omnicell position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 276 Omnicell shares in Q1 2019, an estimated $17K.
Claybrook Capital first reported a position in Omnicell in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Omnicell position peaked at $17K in Q4 2018.
306 funds tracked by Wall St. Rank held Omnicell as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.